Bora Pharmaceuticals is Awarded Outstanding Company of the Year at Bio-Asia Taiwan 2023

July 27, 2023

Bio-Asia Taiwan Exhibition

Taipei, Taiwan

Bora has been awarded “Outstanding Company of the Year” by an independent panel of international judges during Bio-Asia Taiwan exhibit taking place in Taipei, Taiwan July 24-26, 2023. Bora was chosen from a short list of several candidates for its demonstrated leadership in the Taiwan Biopharma industry.

Bobby Sheng said; “Our team’s focused dedication to excellence in quality and customer service continues to be acknowledged by our clients and in BioPharma industry. I’m especially proud of our biologic subsidiary, Bora Biologics, for growing at such a rapid pace and being recognized in the Biopharma community.” 

Bora is currently the only CDMO in Taiwan that has a leading position in both small and large molecules with 6 manufacturing sites with over 70 Billion NTD market cap.

https://boracdmo.com/news-and-events/bora-pharmaceuticals-is-awarded-outstanding-company-of-the-year-at-bio-asia-taiwan-2023/

Company: BORA PHARMACEUTICAL SERVICES INC.


Bora Pharmaceuticals and our group of companies is a publicly-traded company on the Taiwan Stock Exchange (6472). We are Taiwan's largest CDMO with a 50-year history in the Pharmaceutical Industry. We supply drugs to over 100 countries in the world, including the US/Canada, EU, Southeast Asia, Middle East, and South and Central America. We provide outsourced R&D, CDMO, and CMO services for global pharmaceutical companies around the world.

Send Enquiry for this story

By submitting this form you are giving a consent to Worldpharmatoday.com to store your submitted information.
See our Privacy Policy to learn more about how we use data.

RELATED ARTICLESMORE FROM AUTHOR